A US drugmaker producing skin creams for common conditions has raised the price of two of its treatments to almost $10,000 a tube in the latest instance of “gouging” in the world’s largest healthcare market, according to figures seen by the Financial Times.
Novum Pharma
last week more than doubled the price of the ointments, even after similar increases by other drugmakers prompted an outcry and propelled the topic of high healthcare costs into the US presidential campaign.
您已閱讀23%（476字），剩餘77%（1568字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。